Last reviewed · How we verify
Polyethylene Glycol Recombinant Human Somatropin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Polyethylene Glycol Recombinant Human Somatropin (Polyethylene Glycol Recombinant Human Somatropin) — Shandong University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Polyethylene Glycol Recombinant Human Somatropin TARGET | Polyethylene Glycol Recombinant Human Somatropin | Shandong University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Polyethylene Glycol Recombinant Human Somatropin CI watch — RSS
- Polyethylene Glycol Recombinant Human Somatropin CI watch — Atom
- Polyethylene Glycol Recombinant Human Somatropin CI watch — JSON
- Polyethylene Glycol Recombinant Human Somatropin alone — RSS
Cite this brief
Drug Landscape (2026). Polyethylene Glycol Recombinant Human Somatropin — Competitive Intelligence Brief. https://druglandscape.com/ci/polyethylene-glycol-recombinant-human-somatropin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab